このポッドキャストは新しいエピソードをリリースしていない、または一部オーディオが破損している可能性があります。 Maybe this podcast has a new rss feed?

このポッドキャストについて 🔗

更新頻度:
biweekly
平均音声長:
20 minutes
英語
アメリカ合衆国
5 エピソード
2019年10月22日から
episodic

最新エピソード 🔗

Protective gear is in high demand, and it seems everyone is making masks. In this clip, I discuss the requirements for each type of mask, the constantly changing regulations, and the reason why that homemade mask may not offer up any protection after all.

過去のエピソードを検索

LeanRAQA with Michelle Lottの以前のエピソードを検索します。

以前のエピソード

Michelle and Greg talk the technology benefits of launching in Europe, the lack of assessment panelists and the challenges of translating MDR into multiple languages without losing (or changing!) the intention in this second installment from the presentation with the southern California OWL group.
MDR, MDD,  nasal cannulas and the PIP patient safety breakdown - we covered it all at the southern California meeting of the Opthalmic World Leaders (OWL) group.  Join me and Greg Kunst as we talk regulation, clinical validation testing and industrial-grade silicone.
I have seen this time and again. A medical device manufacturer follows the available FDA guidance documents, goes to the pre-submission meeting, presents their case, and leaves feeling that the meeting went well. Imagine the surprise three weeks later when the FDA sends a three-page letter advising…
Michelle chats with MDG's Joe Hage about the fast-approaching May 2020 deadline for implementation of MDR, and a possible idea for extending the deadline. Remember "meaningful use" and the eight stages with targeted implementation dates for adoption of the electronic medical record (EMR)? &nbs…
このポッドキャストのエピソードはすべて視聴済みです
免責: このページに埋め込まれているポッドキャストとアートワークは Michelle Lott からのものであり、その所有者の所有物であり、Listen Notes, Inc. と提携または承認されていません。